Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Tesla Shares Poised for Rally as UBS Raises Delivery Forecast

Felix Baarz by Felix Baarz
September 24, 2025
in Analysis, Automotive & E-Mobility, Nasdaq
0
Tesla Stock
0
SHARES
130
VIEWS
Share on FacebookShare on Twitter

Tesla has received unexpected support from one of the world’s leading investment banks, UBS, which has significantly upgraded its third-quarter delivery projections for the electric vehicle manufacturer. This revised outlook could provide substantial momentum for the company’s stock price, though questions remain about whether this optimism extends beyond temporary tax incentives.

Revised Estimates Signal Strong Quarterly Performance

Market experts at UBS have increased their delivery forecast to 475,000 vehicles for the current quarter, representing a substantial jump from their previous estimate of 431,000 units. This new figure stands approximately 8% above Wall Street’s consensus expectations and would mark a 24% increase compared to the previous quarter’s performance.

The bank attributes this positive revision primarily to unexpectedly robust performance in the United States market. UBS researchers suggest that buyers are rushing to capitalize on the expiring $7,500 federal tax credit, potentially driving quarterly figures to their highest level since mid-2023, if not establishing a new record entirely.

Chinese Market Shows Renewed Strength

Beyond the U.S. market, Tesla is experiencing encouraging developments in the critical Chinese marketplace. Recent data indicates that 17,300 new Tesla vehicles were registered during the third week of September, reflecting a 12.7% weekly increase and reaching the highest level in twelve weeks.

Should investors sell immediately? Or is it worth buying Tesla?

Additional context from the Chinese market includes:
* Deutsche Bank projections anticipating approximately 72,000 total September deliveries in China
* This would represent a monthly increase of roughly 27%
* The newly introduced six-seater Model Y L appears to be a significant growth driver

Divergent Analyst Views Highlight Market Uncertainty

Despite these positive indicators, Tesla’s valuation remains highly contested among financial institutions. While UBS has raised its delivery forecast, the bank maintains its “sell” recommendation with a price target of $215, suggesting substantial potential downside.

This contrasts sharply with Piper Sandler’s recent assessment, which elevated its price target to $500. The majority of market analysts, however, maintain “hold” positions on the stock. This extreme divergence in professional opinion underscores fundamental questions about Tesla’s current valuation: has the stock become overextended following recent gains, or is this merely the beginning of a sustained upward trajectory?

Ad

Tesla Stock: Buy or Sell?! New Tesla Analysis from February 7 delivers the answer:

The latest Tesla figures speak for themselves: Urgent action needed for Tesla investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Tesla: Buy or sell? Read more here...

Tags: Tesla
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Riley Exploration Permian Stock
Analysis

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

February 7, 2026
Next Post
Vici Properties Stock

Vici Properties: Market Hesitation Meets Strategic Expansion

Evolent Health Stock

Evolent Health Sells Primary Care Division in Strategic Shift

WiMi Hologram Cloud Stock

WiMi's Quantum Computing Breakthrough Sparks Sustained Stock Rally

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com